Retraction notice to " IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas” [Canc. Lett., 458 (2019) pages 29–38]
Mihajluk, K., Simms, C., Reay, M., Madureira, P.A., Howarth, A., Murray, P., Nasser, S., Duckworth, C.A., Pritchard, D.M., Pilkington, G.J., Hill, R.
Published in Cancer letters (01.06.2021)
Published in Cancer letters (01.06.2021)
Get full text
Journal Article
Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]
Mihajluk, K., Simms, C., Reay, M., Madureira, P.A., Howarth, A., Murray, P., Nasser, S., Duckworth, C.A., Pritchard, D.M., Pilkington, G.J., Hill, R.
Published in Cancer letters (28.01.2020)
Published in Cancer letters (28.01.2020)
Get full text
Journal Article
RETRACTED: IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating Epidermal Growth Factor Receptor inhibitor resistance in adult high grade gliomas
Mihajluk, K., Simms, C., Reay, M., Madureira, P.A., Howarth, A., Murray, P., Nasser, S., Duckworth, C.A., Pritchard, D.M., Pilkington, G.J., Hill, R.
Published in Cancer letters (28.08.2019)
Published in Cancer letters (28.08.2019)
Get full text
Journal Article